Chicago Capital, LLC Ligand Pharmaceuticals Inc Transaction History

Chicago Capital, LLC

$3.51 Billion
Q1 2025

A detailed history of Chicago Capital, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Chicago Capital, LLC holds 554,517 shares of LGND stock, worth $64.2 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares

554,517

Previous 551,588 0.53%

Holding current value

$64.2 Million

Previous $59.1 Million 1.36%

% of portfolio

1.66%

Previous 1.58%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 17, 2025	BUY	$105.14 - $122.23 $307,955 - $358,011	2,929 Added 0.53%	554,517 $58.3 Million
Q4 2024 Jan 24, 2025	BUY	$99.95 - $129.9 $576,411 - $749,133	5,767 Added 1.06%	551,588 $59.1 Million
Q3 2024 Oct 18, 2024	BUY	$82.7 - $110.11 $2.55 Million - $3.4 Million	30,875 Added 6.0%	545,821 $54.7 Million
Q2 2024 Aug 06, 2024	BUY	$68.53 - $87.91 $19.6 Million - $25.1 Million	285,350 Added 124.28%	514,946 $43.4 Million
Q1 2024 Apr 15, 2024	SELL	$68.64 - $89.2 $131,445 - $170,818	-1,915 Reduced 0.83%	229,596 $16.8 Million
Q4 2023 Jan 22, 2024	SELL	$49.57 - $72.63 $6.39 Million - $9.36 Million	-128,834 Reduced 35.75%	231,511 $16.5 Million
Q3 2023 Oct 25, 2023	SELL	$58.86 - $72.67 $3.75 Million - $4.63 Million	-63,674 Reduced 15.02%	360,345 $21.6 Million
Q2 2023 Jul 20, 2023	SELL	$69.53 - $79.33 $1.77 Million - $2.02 Million	-25,489 Reduced 5.67%	424,019 $30.6 Million
Q1 2023 Apr 18, 2023	BUY	$65.67 - $77.08 $8.57 Million - $10.1 Million	130,454 Added 40.89%	449,508 $33.1 Million
Q4 2022 Jan 20, 2023	SELL	$61.72 - $96.74 $8.66 Million - $13.6 Million	-140,261 Reduced 30.54%	319,054 $0
Q3 2022 Oct 14, 2022	BUY	$0.01 - $107.56 $109 - $1.18 Million	10,952 Added 2.44%	459,315 $39.6 Million
Q2 2022 Jul 21, 2022	SELL	$74.52 - $117.06 $3.23 Million - $5.08 Million	-43,354 Reduced 8.82%	448,363 $40 Million
Q1 2022 Apr 21, 2022	BUY	$94.99 - $151.56 $5.25 Million - $8.38 Million	55,261 Added 12.66%	491,717 $55.3 Million
Q4 2021 Jan 20, 2022	SELL	$127.69 - $165.85 $488,669 - $634,707	-3,827 Reduced 0.87%	436,456 $67.4 Million
Q3 2021 Oct 28, 2021	SELL	$102.33 - $144.73 $1.91 Million - $2.7 Million	-18,672 Reduced 4.07%	440,283 $61.3 Million
Q2 2021 Jul 22, 2021	BUY	$113.03 - $155.64 $1.17 Million - $1.61 Million	10,318 Added 2.3%	458,955 $60.2 Million
Q1 2021 Apr 13, 2021	BUY	$99.52 - $215.83 $11.5 Million - $25 Million	115,783 Added 34.78%	448,637 $68.4 Million
Q4 2020 Jan 25, 2021	SELL	$80.55 - $106.05 $12.3 Million - $16.2 Million	-152,988 Reduced 31.49%	332,854 $33.1 Million
Q3 2020 Oct 13, 2020	BUY	$89.56 - $126.72 $19.4 Million - $27.5 Million	217,081 Added 80.77%	485,842 $46.3 Million
Q2 2020 Jul 29, 2020	BUY	$68.28 - $123.65 $18.4 Million - $33.2 Million	268,761 New	268,761 $30.1 Million

Others Institutions Holding LGND

# of Institutions

280

Shares Held

19M

Call Options Held

9.5K

Put Options Held

8.1K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.95B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital, LLC with notifications on news.

Account

Chicago Capital, LLC Ligand Pharmaceuticals Inc Transaction History